It is not yet clear if N-protein targeting antibodies can also neutralize SARS-CoV-2, however, highly significant correlations were found between the virus neutralization ability of COVID-19 patients’ serum and concentrations of antibodies targeting RBD or N-protein.
← all excerpts
The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector.
1
—
—